Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary - A Global Cost-Effectiveness Model Adaptation

Value Health. 2014 Nov;17(7):A633-4. doi: 10.1016/j.jval.2014.08.2270. Epub 2014 Oct 26.
No abstract available